TRADING UPDATES: Life Science REIT portfolio valuation declines 7.8%
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News: Read More
| Price | 36.80p on 09-01-2026 at 19:20:07 |
|---|---|
| Change | -2.20p -5.64% |
| Buy | 36.80p |
| Sell | 36.30p |
| Last Trade: | Unknown 54,000.00 at 36.80p |
| Day's Volume: | 2,158,161 |
| Last Close: | 36.80p |
| Open: | 38.50p |
| ISIN: | GB00BP5X4Q29 |
| Day's Range | 34.60p - 38.50p |
| 52wk Range: | 32.60p - 49.00p |
| Market Capitalisation: | £128.80m |
| VWAP: | 35.8541p |
| Shares in Issue: | 350.00m |
Life Science (LABS) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Unknown* | 54,000 | 36.80p | OTC Trade |
17:06:31 - 09-Jan-26 |
| Sell* | 60,833 | 36.80p | Uncrossing Trade |
16:35:27 - 09-Jan-26 |
| Buy* | 13,594 | 36.5598p | Ordinary |
16:16:44 - 09-Jan-26 |
| Buy* | 7,290 | 36.56p | Ordinary |
15:52:59 - 09-Jan-26 |
| Buy* | 7,000 | 36.56p | Ordinary |
15:35:59 - 09-Jan-26 |
| Sell* | 100,000 | 36.50p | Ordinary |
15:24:53 - 09-Jan-26 |
| Sell* | 3 | 36.30p | SI Trade |
15:15:53 - 09-Jan-26 |
| Buy* | 3,000 | 36.56p | Ordinary |
15:01:41 - 09-Jan-26 |
| Sell* | 13,681 | 36.5447p | Ordinary |
14:58:15 - 09-Jan-26 |
| Buy* | 5,000 | 36.56p | Ordinary |
14:52:34 - 09-Jan-26 |
Life Science (LABS) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 9th Jan 2026 7:00 am | RNS | Portfolio Valuation and NTA Update |
| 22nd Dec 2025 3:01 pm | RNS | Holding(s) in Company |
| 22nd Dec 2025 3:01 pm | RNS | Holding(s) in Company |
| 16th Dec 2025 5:19 pm | RNS | Holding(s) in Company |
| 3rd Dec 2025 7:00 am | RNS | Appointment of Non-Executive Director |
| 1st Dec 2025 10:17 am | RNS | Holding(s) in Company |
| 26th Nov 2025 4:34 pm | RNS | Holding(s) in Company |
| 24th Nov 2025 3:58 pm | RNS | Result of Meeting |
| 20th Nov 2025 10:12 am | RNS | Holding(s) in Company |
| 19th Nov 2025 10:07 am | RNS | Holding(s) in Company |